Cancer Science Institute of Singapore (CSI)

A Premier Centre for Cutting Edge Cancer Research.

A dynamic research institute encompassing basic and translational studies, devoted to understanding the pathogenesis and treatment of cancer
null

CSI Singapore congratulates Dr. Takaomi Sanda on this award!

Yong Loo Lin School of Medicine Research Excellence Award AY2018/2019

  Read More

null

(Blood, Jan 2020)

Feed-forward Regulatory Loop Driven by IRF4 and NF-kB in Adult T-cell Leukemia/Lymphoma.

  Read More

null

(Gut, Jan 2020)

DNA damage signalling as an anti-cancer barrier in gastric intestinal metaplasia.

  Read More

null

(Mol Cells, Jan 2020)

The RUNX1 Enhancer Element eR1: A Versatile Marker for Adult Stem Cells.

  Read More

null

Researchers from CSI Singapore & ASLAN Pharmaceuticals Make Headway in the Treatment of Acute Myeloid Leukemia (AML)

ASLAN003's potential for treating AML was discovered by research team from CSI Singapore and the National University Health System (NUHS).

  Read More

null

Frontiers in Cancer Science 2019

Highlights from the 11th Frontiers in Cancer Science (FCS) conference which took place at The Academia @ SGH from 4 to 6 November 2019.

  Read More

Giving to CSI

You can help us to shape the next generation of innovative cancer research

null
Epigenetics in Cancer Symposium 2020
Learn More

Upcoming Events

null

CSI Research Meeting
14 February @ 1.00pm
CeTM Lecture, Level 3, MD06

  Read More

null

Bioinformatics Workshop
20 February 2020 - 2pm
#04-01 SMART Classroom

  Read More

null

Epigenetics in Cancer Symposium 2020
2 - 3 March
CRC Audi, MD11

  Read More

null

RNA Biology Symposium 2020
1 - 2 October 2020

  Read More